Chemical Structure (Diltiazem 01)
Diltiazem Hydrochloride
Product Images NDC 0409-1171
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 0409-1171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Diltiazem 02)
Figure 2 (Diltiazem 03)
Figure 3 (Diltiazem 04)
Figure 4 (Diltiazem 05)
Figure 5 (Diltiazem 06)
Figure 6 (Diltiazem 07)
Logo (Diltiazem 08)
Principal Display Panel (5 mL Vial Label)
This is a description of a 25 mg/5 mL (5 mg/mL) Diltiazem HCI injection in a single-dose flip-top vial for direct intravenous bolus injection and continuous intravenous infusion. The product is only available with a prescription and should be used as directed in the insert. The vial has an NDC number of 0409-1171-11 and should be stored between 2° to 8°C (36° to 46°F). The product is manufactured by Hospira, Inc. in Lake Forest, IL, and the lot number and expiration date are provided on the packaging.*
Principal Display Panel (5 mL Vial Carton)
This is a drug description for 10X Sl Single-dose Flip-top vials containing Diltiazem Hydrochloride Injection used for direct intravenous bolus injection and continuous improvement of inflammation. It is refrigerated (but not frozen) and must be stored in accordance with the information provided on the back panel. This drug is produced by Hospira S Hospira and contains citric acid USP, sodium citrate (dihydrate) USP, sodium hydride and/or hydrochloric acid for pH adjustment. The recommended storage temperature is between 2°C to 8°C, and it cannot be stored for more than one month at room temperature. The rest of the information is either illegible or not relevant to the product description.*
Principal Display Panel (10 mL Vial Label)
This is a description of a medicine named "Fiiptop Vial". It comes in a single-dose of 0 mL and is for prescription only with an assigned NDC number. Each mL contains 5 mg of the active ingredient "ditiazem HCI Injection hydrochloride" and other components like citric acid and sodium citrate. The drug is to be stored at a temperature range of 2° to 8°C (36° to 46°F). The recommended dosage should be checked in the insert. The manufacturer is Hospira, Inc. and the label contains information regarding date of removal of refrigeration, expiry date, lot number, and other related details.*
Principal Display Panel (10 mL Vial Carton)
This document appears to be a description of a prescription medication called Diltiazem Hydrochloride Injection. It comes in a 10mL single-dose vial and is used for direct intravenous bolus injection and continuous intravenous infusion. The usual dosage is not provided. It is highlighted that the medication should be stored under refrigeration and not frozen. The text contains information about the contents of the vial, including diltiazem hydrochloride, citric acid, sodium citrate, and sorbitol. The document also provides information about room temperature storage and shelf life.*
Principal Display Panel (100 mg Vial Label)
This text appears to be a description of a medication called Diltiazem HCI for injection. It is a single-dose, sterile powder that is intended for continuous intravenous infusion. Each vial contains freeze-dried powder that comprises 100 mg of diltiazem hydrochloride and 75 mg of Mannitol USP. It is distributed by Hosgira, Inc. The text includes dosage instructions, storage requirements, and contact information for the distributor.*
Principal Display Panel (100 mg Vial Tray)
The text describes a product labeled as "Single-dose ADD-Vantage® Vials Sterile Powder". It contains Diltiazem HCI for Injection intended for continuous intravenous infusion only and should not be used for bolus injections. The instructions on the usual dosage can be found in the insert. The product comes in 10 vials and has an NDC code of 0409-4350-03. The material after reconstitution is stable for 24 hours at controlled room temperature and should be stored between 20 to 25°C . The product is distributed by Hospira, Inc., in America.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
